Amkor Technology, Inc. (NASDAQ:AMKR) Touches a New 52-Week High

The chip packaging and test services provider posted revenue of $1.02 billion in the period. Fabless semiconductor companies focuses on the semiconductor design process and manufacturing process.

For the current quarter ending in April, Amkor Technology said it expects revenue in the range of $860 million to $940 million. The company has a consensus rating of "Hold" and an average target price of $8.18. For the past month, Amkor Technology, Inc.'s stock has been -8.13%, -16.43% for the last quarter, 4.46% for the past six months and 120.41% for the past 52 weeks. Principal Financial Group Inc. now owns 25,064 shares of the company's stock valued at $144,000 after buying an additional 5,925 shares during the last quarter. Company has a market cap of $2,370 M.

Amkor Technology, Inc. (NASDAQ:AMKR) share price Fell -7.95% to reach $9.61 during the last trading session. The high end of the earnings forecast is $0.83 per share and low end is $0.64 per share. Also, Director John Osborne sold 6,994 shares of the business's stock in a transaction that occurred on Monday, November 21st. Amkor Technology, Inc. has P/S value of 0.7 while its P/B value stands at 1.87. As far as the returns are concern, the return on equity was recorded as 4.30% and return on investment was 4.10% while its return on asset stayed at 1.30%. (NASDAQ:AMKR)-0 analysts issued Strong buy for the stock, 0 analysts have given a Buy rating, 2 think it's a HOLD, 0 reported it as Underperform, while 1 analyst issued a Sell rating. Number of analysts are covering this stock and now stock has got OUTPERFORM rating from 23 analysts of Thomson Reuters, 9 analysts given HOLD rating to the stock and 1 given UNDERPERFORM rating.

The Stock now has Analyst' mean Recommendation of 3.7 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell. The stock is now trading 7.39 percent higher from its SMA-50. The median estimate represents a -18.58% decrease from the last price of 10.44.

A number of analysts offered their Estimated Earnings analysis for Amkor Technology, Inc.

Turning to Kate Spade & Company (NYSE:KATE), its shares were trading at $19.61 a gain of $0.83, on the trading floor. The company offers OncoCEE-BR (TM) test for breast cancer. Following the completion of the sale, the insider now owns 188,807 shares of the company's stock, valued at $2,231,698.74. The firm past twelve months price to sales ratio was 0.67 and price to cash ratio remained 4.29.

Average Revenue Estimate for the current quarter is $929.58 Million, according to consensus forecast of 2 analysts. During the same period in the prior year, the firm earned ($0.04) EPS.

In an overview of the current analyst recommendations, Buy count is 9 and Overweight is 1 while the number of analysts recommending Sell and Underweight are 0 and 0, respectively. That puts the market capitalization at $2.47 bln. The stock stands almost -16.35% off versus the 52-week high and 155.26% away from the 52-week low. The company's shares were closed at $9.61. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.15. The difference between the actual and Estimated EPS is $-0.02. The stock is showing its Operating Margin of 4.9 percent.

The company has YTD performance of 180 percent. The Moving Average SMA50 is -0.01% while SMA200 is 20.61%.

Finisar Corporation (FNSR) opened the session with a $34.44 price tag, later ranging from $34.4 to $35.95, the range at which the stock has traded at throughout the day.

  • Carolyn Briggs